Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations

Area of Science:

• Genetics
• Immunology
• Hematology

Background:

• Hereditary angioedema with normal C1-INH (HAE) can be caused by Factor 12 (FXII) gene mutations (HAE-FXII) or unknown genetic factors (HAE-unknown).
• Understanding the differences between these HAE subtypes is crucial for diagnosis and management.

Purpose of the Study:

• To compare the transmission, inheritance, clinical features, and laboratory parameters of HAE-FXII and HAE-unknown.
• To identify key differentiating factors between the two HAE subtypes.

Main Methods:

• A study involving 69 patients with HAE-FXII from 23 families and 196 patients with HAE-unknown from 65 families.
• Analysis of inheritance patterns, age of onset, clinical symptoms, and laboratory markers.

Main Results:

• Both HAE types are autosomal dominant with incomplete penetrance, but HAE-FXII shows a higher female predominance and maternal transmission.
• HAE-FXII has an earlier age of onset (20.3 years) compared to HAE-unknown (29.6 years).
• Estrogen-related factors (pregnancy, oral contraceptives) significantly impact HAE-FXII more than HAE-unknown; some laboratory differences (C1-INH, C4) were noted.

Conclusions:

• HAE-FXII and HAE-unknown exhibit significant differences in gender distribution, genetic transmission, clinical presentation, and response to hormonal influences.
• These distinctions highlight the importance of genetic profiling in HAE diagnosis and personalized treatment strategies.